Introduction
============

ECCO~2~removal may be a useful support in patients with difficult respiratory weaning. The aim of this study is to evaluate a new phosphorylcholine-coated EECO~2~removal system with no thrombogenic activity to assess the clinical safety of the system, the changes of main cardiorespiratory indices and CO~2~removal by the system.

Methods
=======

Ten patients were enrolled. Before starting with ECCO~2~removal all patients were ventilated with TV \<6 ml/kg, peak pressure \>35 cmH~2~O and pH \<7.25. ECCO~2~removal was initiated using a modified continuous venovenous hemofiltration system with a membrane oxygenator (ABYLCAP; Bellco, Mirandola, Italy; membrane surface area: 0.67 m^2^, blood flow 280 to 350 ml/minute, phosphorylcholine coated). Femoral vein cannulation with a double-lumen catheter was used to connect the patients to the extracorporeal system. Heparin was infused to maintain ACT \<190 to 240 seconds. All patients had ECCO~2~for 4 days. Every 12 hours the pH, PaCO~2~, peak pressure and PaO~2~were evaluated. VCO~2~was determined by indirect calorimetry using a gas analyser equipped on an Engstrom Carestation Ventilator. During the ECCO~2~removal the patients were ventilated with TV ≤6 ml/kg and peak pressure \<30 cmH~2~O. All data are expressed as mean ± SD. One-way ANOVA was used to compare the changes of parameters. *P \<*0.05 was considered significant.

Results
=======

Table [1](#T1){ref-type="table"} presents the main results. The CO~2~removal by membrane oxygenator ranged from 56 to 37 ml/minute. All patients survived to the treatment and 7/10 were weaned from the ventilator at the end of ECCO~2~removal. Only one oxygenator was used for every patient without clotting of the circuit or any major bleeding problem.

                      Day 0         Day 2        Day 4
  ------------------- ------------- ------------ ---------------
  pH                  7.24 ± 0.06   7.38 ± 0.1   7.41 ± 0.07\*
  PaCO~2~(mmHg)       70 ± 5        57 ± 8       52 ± 3\*
  PP (cmH~2~O)        48 ± 4        28 ± 4\*     25 ± 4
  VCO~2~(ml/minute)   220 ± 15      201 ± 14     180 ± 13\*

\**P \<*0.05 versus T0.

Conclusion
==========

ECCO~2~removal with a phosphorylcholine-coated membrane oxygenator is clinically safe, avoids clotting of the oxygenator circuit and allows adequate CO~2~removal.
